These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8338995)

  • 21. Management of phenylketonuria: South Australian experience of 13 cases.
    Robertson EF; Hill GN; Cashel K; Rooney J; Brummitt R; Pollard AC
    Med J Aust; 1976 May; 1(18):647-50. PubMed ID: 950936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships between phenylalanine levels, intelligence and socioeconomic status of patients with phenylketonuria.
    Castro IP; Borges JM; Chagas HA; Tibúrcio J; Starling AL; Aguiar MJ
    J Pediatr (Rio J); 2012 Jul; 88(4):353-6. PubMed ID: 22456753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylketonuria and its variants: observations on intellectual functioning.
    Netley C; Hanley WB; Rudner HL
    Can Med Assoc J; 1984 Oct; 131(7):751-5. PubMed ID: 6478363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria.
    Smith I; Beasley MG; Ades AE
    Arch Dis Child; 1991 Mar; 66(3):311-6. PubMed ID: 2025007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early.
    Pietz J; Benninger C; Schmidt H; Scheffner D; Bickel H
    Eur J Pediatr; 1988 May; 147(4):361-7. PubMed ID: 3396592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of intelligence test results in treated phenylketonuric children.
    Williamson ML; Koch R; Azen C; Chang C
    Pediatrics; 1981 Aug; 68(2):161-7. PubMed ID: 7267221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontal lobe-dependent functions in treated phenylketonuria: blood phenylalanine concentrations and long-term deficits in adolescents and young adults.
    Feldmann R; Denecke J; Grenzebach M; Weglage J
    J Inherit Metab Dis; 2005; 28(4):445-55. PubMed ID: 15902547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intelligence in mild atypical phenylketonuria.
    Costello PM; Beasley MG; Tillotson SL; Smith I
    Eur J Pediatr; 1994 Apr; 153(4):260-3. PubMed ID: 8194559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intellectual performance of 36 phenylketonuria patients and their nonaffected siblings.
    Dobson JC; Kushida E; Williamson M; Friedman EG
    Pediatrics; 1976 Jul; 58(1):53-8. PubMed ID: 934784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels.
    González García MB; Conde-Guzon P; Alcalde Martín C; Conde-Guzon MJ; Velasco Zúñiga R
    Arch Argent Pediatr; 2017 Jun; 115(3):267-273. PubMed ID: 28504493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth and skeletal maturation in children with phenylketonuria.
    Schaefer F; Burgard P; Batzler U; Rupp A; Schmidt H; Gilli G; Bickel H; Bremer HJ
    Acta Paediatr; 1994 May; 83(5):534-41. PubMed ID: 8086734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intellectual development in 12-year-old children treated for phenylketonuria.
    Azen CG; Koch R; Friedman EG; Berlow S; Coldwell J; Krause W; Matalon R; McCabe E; O'Flynn M; Peterson R
    Am J Dis Child; 1991 Jan; 145(1):35-9. PubMed ID: 1985428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intelligence and professional career in young adults treated early for phenylketonuria.
    Schmidt H; Burgard P; Pietz J; Rupp A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S97-100. PubMed ID: 8828621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuation vs discontinuation of diet in phenylketonuria.
    Naughten ER
    Eur J Clin Nutr; 1989; 43 Suppl 1():7-12. PubMed ID: 2567666
    [No Abstract]   [Full Text] [Related]  

  • 35. Intellectual, neurologic, and neuropsychologic outcome in untreated subjects with nonphenylketonuria hyperphenylalaninemia. German Collaborative Study on Phenylketonuria.
    Weglage J; Ullrich K; Pietsch M; Fünders B; Güttler F; Harms E
    Pediatr Res; 1997 Sep; 42(3):378-84. PubMed ID: 9284280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurophysiological, psychological, and nutritional investigations during discontinuation of the phenylalanine-restricted diet in children with classic phenylketonuria.
    Pueschel SM; Fogelson-Doyle L; Kammerer B; Matsumiya Y
    J Ment Defic Res; 1983 Mar; 27 (Pt 1)():61-7. PubMed ID: 6615595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A longitudinal study of phenylketonuria based on the data of the Budapest Screening Center.
    Schuler A; Somogyi C; Tôrös I; Pataki L; Mété M; Kiss E; Nagy A
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S50-2. PubMed ID: 8828609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Austrian report on longitudinal outcome in phenylketonuria.
    Scheibenreiter S; Tiefenthaler M; Hinteregger V; Strobl W; Mühl A; Ewald A; Schadler M
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S45-9. PubMed ID: 8828608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The interaction of biological and social factors on the effect of treatment in cases of phenylketonuria (author's transl)].
    Wässer S; Theile H
    Padiatr Padol; 1981; 16(4):417-26. PubMed ID: 7301389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Summary of findings from the United States Collaborative Study of children treated for phenylketonuria.
    Azen C; Koch R; Friedman E; Wenz E; Fishler K
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S29-32. PubMed ID: 8828605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.